Serum and Urine Thioflavin-T-Enhanced Fluorescence in Severe Preeclampsia
- 1 June 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 71 (6), 1185-1192
- https://doi.org/10.1161/HYPERTENSIONAHA.118.11034
Abstract
Common features of amyloid-like proteotoxic aggregates are the ability to bind Congo red (congophilia) and to induce fluorescence of thioflavin-T (ThT), Based on the prior discovery that women with preeclampsia exhibit urine congophilia, we proposed that amyloid-like protein aggregates present in urine also circulate in the bloodstream and this feature is linked to disease severity and clinical phenotype. ThT fluorescence was investigated in 217 paired serum and urine samples from women with severe features of preeclampsia (n=101; median [interquartile range] gestational age [GA], 32 [29-35] weeks), mild features of preeclampsia (n=22, GA, 36 [36-37] weeks), chronic hypertension (n=15; GA, 38 [37-39] weeks), healthy pregnant controls (n=57; GA, 39 [38-39] weeks), and nonpregnant controls (n=22), Scrum and urine fluorescence attributable to advanced glycation end products was measured in the same samples with correction for autofluorescence. There were no GA-related changes in ThT fluorescence, although near-term serum ThT fluorescence increased compared with nonpregnant state, Compared with healthy pregnant controls, serum and urine ThT fluorescence was increased in severe features of preeclampsia (P<0.001 for both) but not in mild features of preeclampsia or chronic hypertension. Except for chronic hypertension, advanced glycation end products related fluorescence of serum or urine did not differ from controls. Urine congophilia had a stronger relationship with preeclampsia severity compared with either urine or SCRIM ThT fluorescence, However, serum ThT fluorescence was independently associated with clinical features of hemolysis, elevated liver enzyme levels, and low platelet levels syndrome (P=0.003), We demonstrate that ThT fluorescence, a marker of amyloid-like aggregates, is increased in scrum of women with preeclampsia and likely because of their cytotoxicity associated with hemolysis, elevated liver enzyme levels, and low platelet levels syndrome.Keywords
This publication has 39 references indexed in Scilit:
- Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnanciesAmerican Journal of Obstetrics and Gynecology, 2017
- Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease RiskJournal of Women's Health, 2016
- Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and CancerCurrent Protein & Peptide Science, 2015
- Mid‐gestational maternal cardiovascular profile in preterm and term pre‐eclampsia: a prospective studyBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Decreased arterial elasticity in formerly early-onset preeclamptic womenActa Obstetricia et Gynecologica Scandinavica, 2011
- Congo red and protein aggregation in neurodegenerative diseasesBrain Research Reviews, 2007
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Atherosclerosis: another protein misfolding disease?Trends in Molecular Medicine, 2002
- Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)American Journal of Obstetrics and Gynecology, 1993
- Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solutionProtein Science, 1993